<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/15F2F01A-5B53-4DC0-A87E-F1802781E6AF"><gtr:id>15F2F01A-5B53-4DC0-A87E-F1802781E6AF</gtr:id><gtr:name>E-Therapeutics Plc</gtr:name><gtr:address><gtr:line1>17 BLENHEIM OFFICE PARK</gtr:line1><gtr:city>LONG HANBOROUGH</gtr:city><gtr:postCode>OX29 8LN</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/15F2F01A-5B53-4DC0-A87E-F1802781E6AF" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>15F2F01A-5B53-4DC0-A87E-F1802781E6AF</gtr:id><gtr:name>E-Therapeutics Plc</gtr:name><gtr:address><gtr:line1>17 BLENHEIM OFFICE PARK</gtr:line1><gtr:city>LONG HANBOROUGH</gtr:city><gtr:postCode>OX29 8LN</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>441968.0</gtr:offerGrant><gtr:projectCost>930735.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ECC4C74D-1D64-4BD7-B9AE-2BFFA1B249B9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>ECC4C74D-1D64-4BD7-B9AE-2BFFA1B249B9</gtr:id><gtr:name>Mirago Technologies Limited</gtr:name><gtr:address><gtr:line1>EQUINOX HOUSE , ORIEL COURT</gtr:line1><gtr:city>ALTON</gtr:city><gtr:postCode>GU34 2YT</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>13910.0</gtr:offerGrant><gtr:projectCost>27820.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5B02CCAA-166B-47D4-BB95-9ACF961BFA5C" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>5B02CCAA-166B-47D4-BB95-9ACF961BFA5C</gtr:id><gtr:name>Eureka Products Limited</gtr:name><gtr:address><gtr:line1>2 LYTTLETON COURT , BIRMINGHAM STREET</gtr:line1><gtr:city>HALESOWEN</gtr:city><gtr:postCode>B63 3HN</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>24679.0</gtr:offerGrant><gtr:projectCost>49357.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8A5AE7C9-9AF7-4753-87D7-7BE110188041" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>8A5AE7C9-9AF7-4753-87D7-7BE110188041</gtr:id><gtr:name>T G Life Sciences Limited</gtr:name><gtr:address><gtr:line1>25 OSBORNE COURT , PARK VIEW ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>W5 2JE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>14164.0</gtr:offerGrant><gtr:projectCost>28327.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6BAA32D3-0592-4662-8707-B8FF49287B99"><gtr:id>6BAA32D3-0592-4662-8707-B8FF49287B99</gtr:id><gtr:firstName>Unknown</gtr:firstName><gtr:otherNames>Unknown</gtr:otherNames><gtr:surname>Unknown</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=100110"><gtr:id>82C90475-2F1B-4FBB-957D-413CC031494C</gtr:id><gtr:title>Third Generation Search (3GS)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>100110</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2009-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2007-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>494721</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">100110</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>